Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,371 | 1,569 | 1,751 | 2,120 | 717 |
| Receivables | N/A | 6 | 301 | N/A | N/A |
| TOTAL | $1,493 | $1,602 | $2,118 | $2,228 | $1,007 |
| Non-Current Assets | |||||
| PPE Net | 13 | 18 | 27 | 37 | 48 |
| Other Non-Current Assets | 16 | 16 | 16 | 16 | 16 |
| TOTAL | $29 | $34 | $43 | $53 | $65 |
| Total Assets | $1,522 | $1,636 | $2,160 | $2,281 | $1,072 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 130 | N/A | N/A | N/A | 2,685 |
| Accounts payable and accrued liabilities | 275 | 131 | 148 | 185 | 409 |
| TOTAL | $502 | $131 | $148 | $185 | $3,094 |
| Non-Current Liabilities | |||||
| Long Term Debt | 170 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 96 | N/A | N/A | N/A | N/A |
| TOTAL | $675 | $625 | $680 | $394 | $408 |
| Total Liabilities | $1,177 | $756 | $828 | $579 | $3,502 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,851 | 17,811 | 17,811 | 17,795 | 17,775 |
| Common Shares | 38,718 | 38,706 | 38,706 | 38,634 | 32,858 |
| Retained earnings | -38,467 | -37,919 | -37,467 | -37,025 | -35,382 |
| TOTAL | $345 | $880 | $1,333 | $1,702 | $-2,431 |
| Total Liabilities And Equity | $1,522 | $1,636 | $2,160 | $2,281 | $1,072 |